Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2386]

AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers

AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers

AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations

AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations

AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER-positive breast cancer

AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER...

AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive...

AACR 2015: Combining two investigational immunotherapy drugs safe, with early signs of effectiveness

AACR 2015: Combining two investigational immunotherapy drugs safe, with early signs of effectiveness

Anti-fungal drug shows promise as potential new cancer treatment

Anti-fungal drug shows promise as potential new cancer treatment

Researchers effectively and safely overcome radiation resistance in leukaemia with an engineered precision medicine

Researchers effectively and safely overcome radiation resistance in leukaemia with an engineered precision medicine

Pioneering breast cancer drugs could work in other cancers

Pioneering breast cancer drugs could work in other cancers

Targeted drug doubles progression-free survival in Hodgkin lymphoma

Targeted drug doubles progression-free survival in Hodgkin lymphoma

Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

More from ecancer